James Crowe’s antibody research lands American Society for Microbiology Award
CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during a record-setting year
VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody
VUMC joins international effort to speed vaccine development
Vanderbilt Vaccine Center joins effort to stop spread of two deadly viruses
Jim Crowe's chikungunya antibody set to enter clinical trial
Team isolates antibodies that neutralize GI bug norovirus
The United States Patent and Trademark Office (USPTO) announced the 2018 Patents for Humanity winners with Vanderbilt University awarded an honorable mention.